|
Headlines
- As the US surpassed 10 million coronavirus cases on Monday, it was the fastest – 10 days - the country had added one million new cases since the pandemic began according to Johns Hopkins University data. [See Extended Stories for a timeline of cases since the outbreak began]
- For the fifth consecutive day, the United States has reported more than 100,000 infections, as 30 states set a record for their seven-day average of new cases amid the worst surge the country has experienced, with Monday marking the third-highest day ever for cases so far, with 118,953, trailing only Saturday and Friday,
- BioNTech's co-founder and chief executive said he was optimistic that the protective effect of its experimental COVID-19 vaccine, co-developed with Pfizer, would last for at least a year.
- Dr. Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, on Monday greeted news about the vaccine against the deadly coronavirus that Pfizer Inc is developing as "a big deal" and said the country could have vaccine doses ready to administer to people before the end of the year.
- The US Food and Drug Administration said Monday it had issued an emergency use authorization for Eli Lilly and Co’s investigational monoclonal antibody therapy bamlanivimab to treat mild to moderate coronavirus infections in adults and children, a drug that in clinical trials helped reduce hospitalizations or emergency room visits in patients at high risk for disease progression.
- An 80% uptake of a COVID-19 vaccine may be needed to protect communities from the novel coronavirus, but volatile levels of misinformation and vaccine mistrust could undermine efforts to tackle the pandemic, with 20% of parents in the US “vaccine hesitant,” according to a recent study in the medical journal Pediatrics, and British scientists finding that, in part due to circulating misinformation and behavioral factors, around 36% of people in Britain say they are either uncertain or very unlikely to agree to be vaccinated against COVID-19.
- Global markets roared Monday, with the Dow Jones industrial average soaring to intraday highs not seen since February as investors welcomed Joe Biden’s White House victory and promising vaccine news, spiking more than 1,600 points before giving back nearly half those gains and ending the session up 834.57 points, or nearly 3%, the S&P 500 advancing 41.06 points, or 1.2%, and the tech-heavy Nasdaq 100, which has seen strong growth throughout the pandemic, tumbling 181.45 points, or more than 1.5%.
|
